Journal of Community Health

, Volume 44, Issue 6, pp 1055–1060 | Cite as

Increasing Birth Cohort Screening for Chronic Hepatitis C in a Primary Care Clinic with Panel Management

  • Christopher Jai BalkissoonEmail author
  • Michelle DeCoux Hampton
Original Paper


Chronic hepatitis C affects millions of people worldwide and patients born between 1945 and 1965 are at elevated risk. Hepatitis C infection can lead to health complications including liver cirrhosis and hepatocellular carcinoma. Recent advancements in direct-acting antiviral treatments have placed the spotlight on primary care providers to identify undiagnosed patients with chronic hepatitis C for treatment and attaining a sustained-virologic response. Primary care providers do not routinely screen patients born between 1945 and 1965 for hepatitis C despite CDC recommendations. To evaluate the effectiveness of a hepatitis C screening protocol implemented in a primary care setting with no prior protocol. A multidisciplinary team was used to implement a hepatitis C screening protocol for patients born between 1945 and 1965 (birth cohort screening). A retrospective analysis was conducted to compare the rate of hepatitis C screening 2 years before and 2 years after the protocol was implemented. Frequency data were collected monthly and tracked in a run chart noting relevant events that affected screening. In the 2 years before the screening protocol began, 81 patients were screened (average = 3 per month); and in the 2 years after the intervention was implemented, a total of 637 patients were screened (average = 25 per month). The protocol was successful in increasing screening rates from 15 to 66% in the 2 years post-intervention. This quality improvement study demonstrated that targeting the birth cohort population was a successful method for increasing hepatitis C screening in a primary care clinic.


Hepatitis C/diagnosis Primary health care Mass screening/methods 


Compliance with Ethical Standards

Conflict of interest

The authors in this study have no conflict of interest or financial gain to report.


  1. 1.
    Almario, C. V., Vega, M., Trooskin, S. B., & Navarro, V. J. (2011). Examining hepatitis C virus testing practices in primary care clinics. Journal of Viral Hepatitis, 19(2), e163–e169. Scholar
  2. 2.
    Apers, L., Berghe, W. V., De Wit, S., Kabeya, K., Callen, S., Buyze, J., et al. (2015). Risk factors for HCV acquisition among HIV-positive MSM in Belgium. JAIDS Journal of Acquired Immune Deficiency Syndromes, 68(5), 585–593. Scholar
  3. 3.
    Ashkani-Esfahani, S., Alavian, S. M., & Salehi-Marzijarani, M. (2017). Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis. World Journal of Gastroenterology, 23(1), 151. Scholar
  4. 4.
    Averhoff, F. M., Glass, N., & Holtzman, D. (2012). Global burden of hepatitis C: Considerations for healthcare providers in the United States. Clinical Infectious Diseases. Scholar
  5. 5.
    Benova, L., Mohamoud, Y. A., Calvert, C., & Abu-Raddad, L. J. (2014). Vertical transmission of hepatitis C virus: Systematic review and meta-analysis. Clinical Infectious Diseases, 59(6), 765–773. Scholar
  6. 6.
    Cachay, E. R., Hill, L., Torriani, F., Ballard, C., Grelotti, D., Aquino, A., & Christopher Mathews, W. (2018). Predictors of missed hepatitis C intake appointments and failure to establish hepatitis C care among patients living with HIV. In Open forum infectious diseases (Vol. 5, No. 7, p. ofy173). Oxford: Oxford University Press.
  7. 7.
    Centers for Disease Control and Prevention. (2017). Hepatitis C facts for health professionals. Retrieved from
  8. 8.
    Centers for Disease Control and Prevention. (2018). People born 1945–1965 (baby boomers). Retrieved from
  9. 9.
    Centers for Disease Control and Prevention. (1998). Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morbidity and Mortality Weekly Report, 47(RR19), 1–39. Retrieved from
  10. 10.
    Coppola, N., De Pascalis, S., Onorato, L., Calò, F., Sagnelli, C., & Sagnelli, E. (2016). Hepatitis B virus and hepatitis C virus infection in healthcare workers. World Journal of Hepatology, 8(5), 273. Scholar
  11. 11.
    Hagan, H., Jordan, A. E., Neurer, J., & Cleland, C. M. (2015). Incidence of sexually-transmitted hepatitis C virus infection in HIV-positive men who have sex with men: A systematic review and meta-analysis. AIDS (London, England), 29(17), 2335. Scholar
  12. 12.
    i2iPopulation Health. (2017). i2iTracks [computer software]. Tennessee: Franklin.Google Scholar
  13. 13.
    Jewett, A., Garg, A., Meyer, K., Wagner, L. D., Krauskopf, K., Brown, K. A., et al. (2015). Hepatitis C virus testing perspectives among primary care physicians in four large primary care settings. Health Promotion Practice, 16(2), 256–263. Scholar
  14. 14.
    Kheirkhah, P., Feng, Q., Travis, L. M., Tavakoli-Tabasi, S., & Sharafkhaneh, A. (2015). Prevalence, predictors and economic consequences of no-shows. BMC Health Services Research, 16(1), 13. Scholar
  15. 15.
    Khodadost, M., Maajani, K., Arabsalmani, M., Mahdavi, N., Tabrizi, R., & Alavian, S. M. (2017). Is tattooing a risk factor for hepatitis C transmission? An updated systematic review and meta-analysis. Hepatitis Monthly. Scholar
  16. 16.
    Kinner, S. A., Snow, K., Wirtz, A. L., Altice, F. L., Beyrer, C., & Dolan, K. (2018). Age-specific global prevalence of hepatitis B, hepatitis C, HIV, and tuberculosis among incarcerated people: A systematic review. Journal of Adolescent Health, 62(3), S18–S26. Scholar
  17. 17.
    Litaker, D., Mion, L. C., Planavsky, L., Kippes, C., Mehta, N., & Frolkis, J. (2003). Physician–nurse practitioner teams in chronic disease management: The impact on costs, clinical effectiveness, and patients’ perception of care. Journal of Interprofessional Care, 17(3), 223–237. Scholar
  18. 18.
    Mahajan, R., Liu, S. J., Klevens, R. M., & Holmberg, S. D. (2013). Indications for testing among reported cases of HCV infection from enhanced hepatitis surveillance sites in the United States, 2004–2010. American Journal of Public Health, 103(8), 1445–1449. Scholar
  19. 19.
    Mehta, S. H., Astemborski, J., Kirk, G. D., Strathdee, S. A., Nelson, K. E., Vlahov, D., et al. (2011). Changes in blood-borne infection risk among injection drug users. Journal of Infectious Diseases, 203(5), 587–594. Scholar
  20. 20.
    Page, K., Hahn, J. A., Evans, J., Shiboski, S., Lum, P., Delwart, E., et al. (2009). Acute hepatitis C virus infection in young adult injection drug users: A prospective study of incident infection, resolution, and reinfection. The Journal of Infectious Diseases, 200(8), 1216–1226. Scholar
  21. 21.
    Platt, L., Easterbrook, P., Gower, E., McDonald, B., Sabin, K., McGowan, C., et al. (2016). Prevalence and burden of HCV co-infection in people living with HIV: A global systematic review and meta-analysis. The Lancet infectious diseases, 16(7), 797–808. Scholar
  22. 22.
    Shehab, T. M., Sonnad, S. S., & Lok, A. S. (2001). Management of hepatitis C patients by primary care physicians in the USA: Results of a national survey. Journal of Viral Hepatitis, 8(5), 377–383. Scholar
  23. 23.
    Smith, B. D., Morgan, R. L., Beckett, G. A., Falck-Ytter, Y., Holtzman, D., Teo, C. G. et al. (2012). Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965. Morbidity and Mortality Weekly Report: Recommendations and Reports61(4), 1–32. Retrieved from
  24. 24.
    Teles, S. A., Gir, E., Martins, R. M. B., dos Santos Carneiro, M. A., de Matos, M. A., & Caetano, K. A. A. (2017). Emergent predictors of hepatitis C infection among non-injection drug users. Journal of Infection and Public Health. Scholar
  25. 25.
    Trinh, J., & Turner, N. (2018). Improving adherence to hepatitis C screening guidelines. BMJ Open Qual, 7(2), e000108. Scholar
  26. 26.
    Turner, B. J., Taylor, B. S., Hanson, J., Liang, Y., Veerapaneni, P., Villarreal, R., et al. (2015). High priority for hepatitis C screening in safety net hospitals: Results from a prospective cohort of 4582 hospitalized baby boomers. Hepatology, 62(5), 1388–1395. Scholar
  27. 27.
    Westbrook, R. H., & Dusheiko, G. (2014). Natural history of hepatitis C. Journal of Hepatology, 61(1), S58–S68. Scholar
  28. 28.
    Wong, S., & Crowley, M. (2016). Utilizing collaborative learning networks to build capacity for hepatitis C treatment in community health centers. Retrieved from
  29. 29.
    World Health Organization. (2017). Hepatitis C. Retrieved from
  30. 30.
    Yartel, A. K., Rein, D. B., Brown, K. A., Krauskopf, K., Massoud, O. I., Jordan, C., et al. (2017). Hepatitis C virus testing for case identification in persons born during 1945–1965: Results from three randomized controlled trials. Hepatology, 67(2), 524–533. Scholar
  31. 31.
    Zou, S., Dorsey, K. A., Notari, E. P., Foster, G. A., Krysztof, D. E., Musavi, F., et al. (2010). Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion, 50(7), 1495–1504. Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Samuel Merritt UniversityOaklandUSA
  2. 2.San Jose State UniversitySan JoseUSA

Personalised recommendations